UNION CITY, Calif.,
May 21, 2014 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company
manufacturing point-of-care blood analysis systems, announced today
that Clint Severson, chairman and
chief executive officer , will present at the Stifel Dental &
Veterinary Conference 2014 on Wednesday, May
28, 2014 at 10:50 a.m. ET. The
conference will be held at Peninsula Hotel in New York City.
About Abaxis
Abaxis develops, manufactures, markets and sells portable blood
analysis systems for use in any veterinary or human patient-care
setting to provide clinicians with rapid blood constituent
measurements. The system consists of a compact, 5.1 kilogram
(11.2 pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs that contain all the chemicals required
to perform a panel of up to 13 tests on veterinary patients and 14
tests on human patients. The system can be operated with
minimal training and performs multiple routine tests on whole
blood, serum or plasma samples. The system provides test
results in less than 12 minutes with the precision and accuracy
equivalent to a clinical laboratory analyzer. The veterinary
business also provides to the animal health and research market a
line of hematology instruments for point-of-care complete blood
counts (CBC), a specialty instrument to screen for and detect
clotting disorders and to measure equine fibrinogen levels, a
handheld instrument for the rapid assessment of certain critical
care tests and rapid point-of-care tests for Heartworm infections,
Parvovirus, Giardia and Lyme disease. Abaxis, through its
AVRL division, provides routine laboratory testing as well as
specialty testing for veterinarians nationwide. For more
information, visit http://www.abaxis.com.
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
ABAXIS,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
SOURCE Abaxis, Inc.